维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Spector NL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor-2 positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
2	Growth arrest of huma n B lymphocytes is accompanied by induction of the low molecular weight mammali an heat shock protein 显示文摘	Samson W Ryan C	1992	J Immunol1992，148，：	1
3	Understanding the mechanisms behindtrastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
4	Understanding the mechanisms behind tr-astuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
5	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2- positive breast cancer 显示文摘	Spector NL Blackwell KL	2009	J Clin Oneol2009，27，34：	1
6	Study of the biologic effects of lapatinib,a reversible inhibitor of ErbBl and ErbB2 tyrosine kinases,on tumor growth and survival pathways in patients with advanced malignancies显示文摘	Spector NL Xia W Burris H	2005	J Clin Oncol2005，23，11：	1
7	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer显示文摘	Spector NL Blackwell KL		0，，34：	1
8	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth fac- tor receptor 2-pnsitive breast cancer 显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
9	Study of the biologic effects of lapatinib,a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases,on tumor growth and survival pathways in patients with advanced malignancies显示文摘	Spector NL Xia W Burris H 3rd		0，，11：	1
10	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor2-positive breast cancer 显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
11	Epoxyeicosatrienoic acids (EETs):metabolism and biochemical function显示文摘	Spector AA Fang X Snyder GD Weintraub NL	2004	Prog Lipid Res2004，43，1：	1
12	Understanding the mechanismsbehind trastuzumab therapy for human epidermal growth factorreceptor 2 positive breast cancer 显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
13	Understanding the mechanisms behind trastuumab therapy for human epidermal growth factor receptor 2- positive breastcancer 显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
14	EGF103009, a phase Ⅱ trial of lapatinib monotherapy in patients with relapsed/refraetory inflammatory breast cancer ( IBC ) : Clinical activity and biologic predictors of response 显示文摘	Spector NL Blackwell K Hurley J	2006	J Clin Oncol2006，24，18：	1
15	Study of the biologic effects of iapatinib a reversible inhitor of EvbB1 and HER-2 tyrosine kinases,on tumor growth and survival pathways in patients with advanced malignancies显示文摘	Spector NL Xia W Burris H 3rd	2005	Clin oncol2005，23，11：	1
16	Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EG- FR/ErbB2 kinase inhibitor GW572016显示文摘	Xia W Liu LHHo P Spector NL	2004	Oncogene2004，23，3：	1
17	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
18	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2 positive breast cancer显示文摘	Spector NL Blackwell KL		0，，34：	1
19	Understanding the mechanism behind trastuzumab therapy for human epidermal growth factor receptor 2 positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1
20	Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer显示文摘	Spector NL Blackwell KL	2009	J Clin Oncol2009，27，34：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示